English  |  正體中文  |  简体中文  |  總筆數 :2853537  
造訪人次 :  45270771    線上人數 :  979
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至:
或輸入年份:
從最近的開始 由舊到新排序

顯示項目 2234066-2234075 / 2346473 (共234648頁)
<< < 223402 223403 223404 223405 223406 223407 223408 223409 223410 223411 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-09-01T01:53:47Z Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3 Huang C.-Y.; Lin C.-S.; Tai W.-T.; Hsieh C.-Y.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F.
臺大學術典藏 2021-09-01T01:53:47Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:48Z Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: Complete response to combined intrathecal and systemic rituximab Huang H.-C.; ANN-LII CHENG; Lin C.-W.; Kuo S.-H.
臺大學術典藏 2021-09-01T01:53:48Z Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway Ou D.-L.; Lee B.-S.; Chang Y.-C.; Lin L.-I.; Liou J.-Y.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:48Z Randomized phase iii study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: Gest study Ueno H.; Ioka T.; Ikeda M.; Ohkawa S.; Yanagimoto H.; Boku N.; Fukutomi A.; Sugimori K.; Baba H.; Yamao K.; Shimamura T.; Sho M.; Kitano M.; ANN-LII CHENG; Mizumoto K.; Chen J.-S.; Furuse J.; Funakoshi A.; Hatori T.; Yamaguchi T.; Egawa S.; Sato A.; Ohashi Y.; Okusaka T.; Tanaka M.
臺大學術典藏 2021-09-01T01:53:48Z No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply Kuo S.-H.; Weng W.-H.; Yeh K.-H.; Chen L.-T.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:49Z Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; ANN-LII CHENG; Cheng J.C.-H.
臺大學術典藏 2021-09-01T01:53:49Z Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma Lu L.-C.; Shao Y.-Y.; Kuo R.N.C.; Lin Z.-Z.; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; ANN-LII CHENG; Lai M.-S.
臺大學術典藏 2021-09-01T01:53:50Z Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation Lin C.-H.; Liu J.M.; Lu Y.-S.; Lan C.; Lee W.-C.; Kuo K.-T.; Wang C.-C.; Chang D.-Y.; Huang C.-S.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:50Z Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome Yu H.-C.; Hou D.-R.; Liu C.-Y.; Lin C.-S.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F.

顯示項目 2234066-2234075 / 2346473 (共234648頁)
<< < 223402 223403 223404 223405 223406 223407 223408 223409 223410 223411 > >>
每頁顯示[10|25|50]項目